Lee Ainslie’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.75M Buy
+96,528
New +$2.57M 0.02% 72
2021
Q4
– Sell
-23,648
Closed -$1.02M – 555
2021
Q3
$1.02M Buy
+23,648
New +$1.05M 0.01% 310
2020
Q4
– Sell
-18,386
Closed -$640K – 751
2020
Q3
$640K Sell
18,386
-123,707
-87% -$4.34M 0.01% 389
2020
Q2
$4.41M Buy
142,093
+132,493
+1,380% +$4.5M 0.09% 64
2020
Q1
$297K Buy
+9,600
New +$327K 0.01% 404
2019
Q1
– Sell
-168,187
Closed -$6.96M – 314
2018
Q4
$6.96M Sell
168,187
-47,830
-22% -$1.99M 0.1% 116
2018
Q3
$9.03M Buy
+216,017
New +$8.32M 0.11% 86
2017
Q4
– Sell
-7,713,604
Closed -$261M – 203
2017
Q3
$261M Sell
7,713,604
-2,881,806
-27% -$92.6M 3.32% 13
2017
Q2
$338M Sell
10,595,410
-10,309,075
-49% -$325M 4.23% 6
2017
Q1
$679M Sell
20,904,485
-3,181,070
-13% -$100M 8.66% 1
2016
Q4
$742M Buy
24,085,555
+1,550,872
+7% +$47.3M 9.66% 1
2016
Q3
$724M Buy
22,534,683
+3,112,811
+16% +$104M 8.58% 1
2016
Q2
$649M Buy
19,421,872
+10,745,025
+124% +$343M 8.81% 1
2016
Q1
$244M Sell
8,676,847
-3,232,249
-27% -$92.3M 3.86% 9
2015
Q4
$365M Buy
11,909,096
+4,596,520
+63% +$145M 5.25% 4
2015
Q3
$218M Buy
+7,312,576
New +$234M 3.73% 10

Other funds holding PFE

Lee Ainslie's PFE Position: Q3 2026 in Review

Lee Ainslie opened a new position in Pfizer (PFE) in Q3 2026: 96,528 shares worth $2.75M. The stake represents 0.02% of the portfolio and ranks #72 among its holdings. This is a return to the name: Lee Ainslie previously reported a position in PFE as recently as Q3 2021.

Lee Ainslie first reported a position in PFE in Q3 2015 and has held it in 16 quarters since. The position peaked at $742M in Q4 2016. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Lee Ainslie held 96,528 shares of Pfizer worth $2.75M as of Q3 2026.
  • Pfizer was a new Lee Ainslie position in Q3 2026.
  • Pfizer made up 0.02% of Lee Ainslie's portfolio in Q3 2026, its #72 holding.
  • Lee Ainslie first reported a position in Pfizer in Q3 2015 and has held it in 16 quarters since.
  • Lee Ainslie's Pfizer position peaked at $742M in Q4 2016.
  • 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Maverick Capital's 13F filing for Q3 2026, filed 16 Nov 2026.